Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Breast Cancer in Hong Kong Chinese Women Through Personalized Risk Stratification and Characterization: an Epidemiologic Modeling Study and the Development of a Biorepository of Cases and Controls

NCT02889458 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT02889458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Breast Cancer in Hong Kong Chinese Women Through Personalized Risk Stratification and Characterization: an Epidemiologic Modeling Study and the Development of a Biorepository of Cases and Controls
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2016
Completion date
December 31, 2028
Enrollment
7,000 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ductal carcinoma in situ